223 related articles for article (PubMed ID: 31026062)
1. A new insight on serum microRNA expression as novel biomarkers in breast cancer patients.
Bahmanpour Z; Sheervalilou R; Choupani J; Shekari Khaniani M; Montazeri V; Mansoori Derakhshan S
J Cell Physiol; 2019 Nov; 234(11):19199-19211. PubMed ID: 31026062
[TBL] [Abstract][Full Text] [Related]
2. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
Wu X; Somlo G; Yu Y; Palomares MR; Li AX; Zhou W; Chow A; Yen Y; Rossi JJ; Gao H; Wang J; Yuan YC; Frankel P; Li S; Ashing-Giwa KT; Sun G; Wang Y; Smith R; Robinson K; Ren X; Wang SE
J Transl Med; 2012 Mar; 10():42. PubMed ID: 22400902
[TBL] [Abstract][Full Text] [Related]
3. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
4. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters.
Swellam M; El Magdoub HM; Hassan NM; Hefny MM; Sobeih ME
Clin Biochem; 2018 Jun; 56():47-54. PubMed ID: 29679553
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
Si H; Sun X; Chen Y; Cao Y; Chen S; Wang H; Hu C
J Cancer Res Clin Oncol; 2013 Feb; 139(2):223-9. PubMed ID: 23052693
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA and cyclooxygenase-2 in breast cancer.
Li W; Zhang Z; Wang B; Liang N; Zhou Q; Long S
Clin Chim Acta; 2021 Nov; 522():36-44. PubMed ID: 34389281
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
10. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
12. Exercise and weight loss interventions and miRNA expression in women with breast cancer.
Adams BD; Arem H; Hubal MJ; Cartmel B; Li F; Harrigan M; Sanft T; Cheng CJ; Pusztai L; Irwin ML
Breast Cancer Res Treat; 2018 Jul; 170(1):55-67. PubMed ID: 29511965
[TBL] [Abstract][Full Text] [Related]
13. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
[TBL] [Abstract][Full Text] [Related]
14. Assessment of circulating HISLA as a potential biomarker for breast cancer diagnosis and prognosis.
Hu H; Hu J; Yang Y; Zhou W; Ye C
Clin Exp Med; 2021 Feb; 21(1):29-34. PubMed ID: 33123839
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer.
Ewida HA; Shabayek M; Seleem M
Breast Dis; 2021; 40(4):241-250. PubMed ID: 34092580
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer.
Ali OS; Shabayek MI; Seleem MM; Abdelaziz HG; Makhlouf DO
Clin Breast Cancer; 2018 Dec; 18(6):e1373-e1379. PubMed ID: 30143449
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.
Godfrey AC; Xu Z; Weinberg CR; Getts RC; Wade PA; DeRoo LA; Sandler DP; Taylor JA
Breast Cancer Res; 2013 May; 15(3):R42. PubMed ID: 23705859
[TBL] [Abstract][Full Text] [Related]
19. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers.
Mar-Aguilar F; Rodríguez-Padilla C; Reséndez-Pérez D
Methods Mol Biol; 2014; 1165():71-80. PubMed ID: 24839019
[TBL] [Abstract][Full Text] [Related]
20. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
